Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy
Clinical trial NCT00063154 · COMPLETED
Trial details
- NCT number
- NCT00063154
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2005-04-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.